C

Cannara Biotech Inc
XTSX:LOVE

Watchlist Manager
Cannara Biotech Inc
XTSX:LOVE
Watchlist
Price: 1.71 CAD 1.18% Market Closed
Market Cap: 162.3m CAD

Wall Street
Price Targets

LOVE Price Targets Summary
Cannara Biotech Inc

Wall Street analysts forecast LOVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LOVE is 3.57 CAD with a low forecast of 3.54 CAD and a high forecast of 3.68 CAD.

Lowest
Price Target
3.54 CAD
107% Upside
Average
Price Target
3.57 CAD
109% Upside
Highest
Price Target
3.68 CAD
115% Upside
Cannara Biotech Inc Competitors:
Price Targets
AFT
AFT Pharmaceuticals Ltd
27% Upside
GLAND
Gland Pharma Ltd
21% Upside
SNDL
Sundial Growers Inc
244% Upside
NATCOPHARM
Natco Pharma Ltd
4% Upside
PBH
Prestige Consumer Healthcare Inc
27% Upside
INVA
Innoviva Inc
67% Upside
688526
Wuhan Keqian Biology Co Ltd
45% Upside
UCB
Ucb SA
11% Upside

Revenue
Forecast

Revenue Estimate
Cannara Biotech Inc

For the last 6 years the compound annual growth rate for Cannara Biotech Inc's revenue is 93%. The projected CAGR for the next 2 years is 14%.

93%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Cannara Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Cannara Biotech Inc

The compound annual growth rate of Cannara Biotech Inc's net income for the next 2 years is 21%.

N/A
Past Growth
21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LOVE's stock price target?
Price Target
3.57 CAD

According to Wall Street analysts, the average 1-year price target for LOVE is 3.57 CAD with a low forecast of 3.54 CAD and a high forecast of 3.68 CAD.

What is Cannara Biotech Inc's Revenue forecast?
Projected CAGR
14%

For the last 6 years the compound annual growth rate for Cannara Biotech Inc's revenue is 93%. The projected CAGR for the next 2 years is 14%.

What is Cannara Biotech Inc's Net Income forecast?
Projected CAGR
21%

The compound annual growth rate of Cannara Biotech Inc's net income for the next 2 years is 21%.

Back to Top